Skip to main content
. Author manuscript; available in PMC: 2015 Feb 1.
Published in final edited form as: Int J Stroke. 2014 May 20;9(6):698–704. doi: 10.1111/ijs.12292

Table 1.

Patient characteristics

All Solitaire SWIFT +
STAR (n = 291)
SWIFT randomized
to Solitaire (n = 58)
SWIFT randomized
to Merci (n = 55)
P value (Merci
vs. Solitaire)
Age 67·8 ± 12·6 67·1 ± 12·0 67·1 ± 12·1 0·99
NIHSS 17 (13–20) 18 (14–19) 18 (13–22) 0·67
HTN 63·9% (186/291) 72·4% (42/58) 69·1% (38/55) 0·84
DM 18·6% (54/291) 24·1% (14/58) 30·9% (17/55) 0·53
AF 39·5% (115/291) 44·8% (26/58) 67·3% (37/55) 0·02
Female 58·4% (170/291) 51·7% (30/58) 49·1% (27/55) 0·85
IV thrombolytics 55·3% (161/291) 32·8% (19/58) 47·2% (25/55) 0·17
sICH 1·4% (4/291) 1·7% (1/58) 10·9% (6/55) 0·06
Proximal clot 86·5% (244/285) 87·9% (51/58) 77·4% (41/53) 0·21
THRIVE score 4 (3–6) 4·5 (3–6) 5 (4–6) 0·18
HIAT score 1 (1–2) 1 (1–2) 1 (1–2) 0·94
HIAT-2 score 2 (2–4) 2 (1–4) 3 (2–4) 0·25
SPAN-100 8·1% (23/285) 8·6% (5/58) 7·3% (4/55) 1·00

Categories in columns are All Solitaire = all patients in Solitaire run-in phase of SWIFT + all patients randomized to Solitaire in SWIFT RCT + all patients in STAR; SWIFT-Merci = all patients randomized to Merci in SWIFT RCT; SWIFT-Solitaire = all patients randomized to Solitaire in SWIFT RCT. Age is presented as mean ± SD. NIHSSand other ordinal scores are presented as median [interquartile range (IQR)]. Dichotomous values (comorbidities, gender, and SPAN-100) are presented as % (number out of total). Between the categories of SWIFT-Merci and SWIFT-Solitaire, continuous data were compared by the nonparametric Wilcoxon rank-sum test, and categorical data were compared by Fisher's exact test. IV thrombolytics = use of IV thrombolytics prior to the procedure. sICH = occurrence of symptomatic ICH within 24 h of the procedure. Proximal clot = occlusion of intracranial ICA, proximal MCA (M1 segment), basilar artery.

AF, atrial fibrillation; DM, diabetes mellitus; HIAT, Houston Intra-Arterial Therapy score; HTN, hypertension; ICA, internal carotid artery; ICH, intracerebral haemorrhage; IV, intravenous; MCA, middle cerebral artery; NIHSS, National Institutes of Health Stroke Scale; RCT, randomized controlled trial; SD, standard deviation; sICH, symptomatic intracerebral haemorrhage; SPAN, Stroke Prognostication using Age and NIH Stroke Scale score; THRIVE, totaled health risks in vascular events.